Delivery Order SPE2DE24D0013-SPE2D626F40M6
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $10,000 firm fixed-price delivery order on November 24, 2025, for COVID-19, influenza, and respiratory syncytial virus diagnostic supplies. The delivery order, valued at the ceiling amount, is scheduled for completion by December 2, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's...
- The Defense Logistics Agency Medical Supply Chain awarded a $10,550 firm fixed-price delivery order to Cepheid Inc. on November 3, 2025, for the Kit Xpert Xpress COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) plus Molecular Biology diagnostic testing supplies. The delivery order, which will be completed by November 10, 2025, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic solutions. This contract is not subject to any small business...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,238.72 to Cepheid Inc. on December 5, 2025, for COVID-19, influenza, and respiratory syncytial virus diagnostic reagents and test kits. The contract, designated as XPCOV2/FLU/RSV-10, carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by December 12, 2025. Performance will occur at Cepheid's headquarters in Sunnyvale, California. This delivery order represents...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery...
- The Defense Logistics Agency's Medical Supply Chain branch awarded a $34,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer based in Sunnyvale, California, for 10 tests of a COVID-19/Influenza/RSV diagnostic kit. The contract, issued on May 29, 2025, is scheduled for completion by June 6, 2025, with performance taking place in Sunnyvale. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing support to federal...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $21,888.40 firm fixed-price delivery order on December 5, 2025, for COVID-19/Influenza/RSV diagnostic supplies, with completion targeted for December 12, 2025. This delivery order, issued without set-aside designation, represents procurement under the agency's medical supply chain operations and aligns with Cepheid's established role as a primary federal supplier of molecular diagnostic testing solutions. The work will be...
- The Defense Logistics Agency issued a $34,223.80 firm fixed-price delivery order to Cepheid Inc. on September 15, 2025, for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing supplies and services. The contract, designated as XPCOV2/FLU/RSV-10, carries an ultimate completion date of September 22, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order does not utilize a set-aside designation and represents a continuation of...
- The Defense Logistics Agency, under its Medical Supply Chain division, awarded a $13,547.30 firm fixed-price delivery order to Cepheid Inc. on August 14, 2025, for respiratory and influenza diagnostic solutions. The contract, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This delivery order carries no set-aside designation and represents procurement under one of Cepheid's existing federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a $30,678.60 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) testing solutions. The contract, which carries no set-aside designation, was executed on August 19, 2025, with an ultimate completion date of August 26, 2025. This delivery order is likely issued under one of Cepheid's existing Indefinite...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F40M6Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on December 18, 2025, for a COVID-19/Influenza/Respiratory Syncytial Virus (RSV) diagnostic kit containing 10 test viruses. The contract, which represents a delivery order rather than a standalone agreement, is scheduled for completion by December 26, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This award carries no set-aside designation and reflects the continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions across the Defense Health Agency and its medical supply chain operations. Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, has demonstrated substantial federal contracting experience through multiple prime and delivery order awards across the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company maintains two significant Indefinite Delivery Contracts with the VA, including a $32.8 million agreement with VISN 6 extending through September 2030 for diagnostic reagents and assays. This modest delivery order for respiratory pathogen testing kits aligns with Cepheid's core competency in providing GeneXpert diagnostic platform supplies and reflects the continued demand for multiplex respiratory testing capabilities within the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 12/17/25 |